Compare with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DIVIS LABORATORIES ALKEM LABORATORIES/
DIVIS LABORATORIES
 
P/E (TTM) x 21.2 40.3 52.7% View Chart
P/BV x 4.8 11.1 43.5% View Chart
Dividend Yield % 1.0 0.5 195.9%  

Financials

 ALKEM LABORATORIES   DIVIS LABORATORIES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
DIVIS LABORATORIES
Mar-21
ALKEM LABORATORIES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,1503,913 80.5%   
Low Rs2,2241,824 121.9%   
Sales per share (Unadj.) Rs741.4262.5 282.4%  
Earnings per share (Unadj.) Rs135.374.7 181.0%  
Cash flow per share (Unadj.) Rs158.384.4 187.6%  
Dividends per share (Unadj.) Rs30.0020.00 150.0%  
Avg Dividend yield %1.10.7 160.1%  
Book value per share (Unadj.) Rs616.8350.1 176.2%  
Shares outstanding (eoy) m119.57265.47 45.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.610.9 33.2%   
Avg P/E ratio x19.938.4 51.7%  
P/CF ratio (eoy) x17.034.0 49.9%  
Price / Book Value ratio x4.48.2 53.2%  
Dividend payout %22.226.8 82.9%   
Avg Mkt Cap Rs m321,244761,517 42.2%   
No. of employees `000NANA-   
Total wages/salary Rs m16,2108,258 196.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m88,65069,694 127.2%  
Other income Rs m2,332627 372.1%   
Total revenues Rs m90,98270,321 129.4%   
Gross profit Rs m19,42428,611 67.9%  
Depreciation Rs m2,7462,556 107.4%   
Interest Rs m58921 2,805.7%   
Profit before tax Rs m18,42126,660 69.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2436,818 32.9%   
Profit after tax Rs m16,17819,843 81.5%  
Gross profit margin %21.941.1 53.4%  
Effective tax rate %12.225.6 47.6%   
Net profit margin %18.228.5 64.1%  
BALANCE SHEET DATA
Current assets Rs m69,28867,906 102.0%   
Current liabilities Rs m36,04117,284 208.5%   
Net working cap to sales %37.572.6 51.6%  
Current ratio x1.93.9 48.9%  
Inventory Days Days2010 205.4%  
Debtors Days Days66878 7.5%  
Net fixed assets Rs m34,82545,963 75.8%   
Share capital Rs m239531 45.0%   
"Free" reserves Rs m73,51792,415 79.6%   
Net worth Rs m73,75692,946 79.4%   
Long term debt Rs m3430-   
Total assets Rs m104,114113,869 91.4%  
Interest coverage x32.31,270.5 2.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 139.1%   
Return on assets %16.117.4 92.3%  
Return on equity %21.921.3 102.7%  
Return on capital %25.728.7 89.4%  
Exports to sales %22.10-   
Imports to sales %018.8 0.0%   
Exports (fob) Rs m19,555NA-   
Imports (cif) Rs mNA13,127 0.0%   
Fx inflow Rs m19,55558,877 33.2%   
Fx outflow Rs m2,46713,341 18.5%   
Net fx Rs m17,08845,536 37.5%   
CASH FLOW
From Operations Rs m12,64919,469 65.0%  
From Investments Rs m-9,985751 -1,329.1%  
From Financial Activity Rs m-2,718-349 778.9%  
Net Cashflow Rs m-1719,872 -0.1%  

Share Holding

Indian Promoters % 57.1 51.9 110.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.6 36.8 53.2%  
FIIs % 5.4 18.5 29.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 48.1 89.2%  
Shareholders   81,869 309,397 26.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


May 23, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS